Collagen IV


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
Historique:
received: 29 12 2020
revised: 11 03 2021
accepted: 24 03 2021
pubmed: 30 3 2021
medline: 21 8 2021
entrez: 29 3 2021
Statut: ppublish

Résumé

We identified a genetic variant, an 8-residue appendage, of the α345 hexamer of collagen IV present in patients with glomerular basement membrane diseases, Goodpasture's disease and Alport syndrome, and determined the long-awaited crystal structure of the hexamer. We sought to elucidate how variants cause glomerular basement membrane disease by exploring the mechanism of the hexamer assembly. Chloride ions induced in vitro hexamer assembly in a composition-specific manner in the presence of equimolar concentrations of α3, α4, and α5 NC1 monomers. Chloride ions, together with sulfilimine crosslinks, stabilized the assembled hexamer. Furthermore, the chloride ion-dependent assembly revealed the conformational plasticity of the loop-crevice-loop bioactive sites, a critical property underlying bioactivity and pathogenesis. We explored the native mechanism by expressing recombinant α345 miniprotomers in the cell culture and characterizing the expressed proteins. Our findings revealed NC1-directed trimerization, forming protomers inside the cell; hexamerization, forming scaffolds outside the cell; and a Cl gradient-signaled hexamerization. This assembly detail, along with a crystal structure, provides a framework for understanding hexamer dysfunction. Restoration of the native conformation of bioactive sites and α345 hexamer replacement are prospective approaches to therapeutic intervention.

Identifiants

pubmed: 33775696
pii: S0021-9258(21)00372-0
doi: 10.1016/j.jbc.2021.100592
pmc: PMC8099640
pii:
doi:

Substances chimiques

Collagen Type IV 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

100592

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK018381
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK065138
Pays : United States
Organisme : NIDDK NIH HHS
ID : R24 DK103067
Pays : United States
Organisme : NIDDK NIH HHS
ID : R25 DK096999
Pays : United States

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Références

J Cell Sci. 2018 Apr 9;131(7):
pubmed: 29632050
J Biol Chem. 2007 Apr 6;282(14):10670-7
pubmed: 17293596
N Engl J Med. 2003 Jun 19;348(25):2543-56
pubmed: 12815141
Nat Rev Nephrol. 2021 Feb;17(2):112-127
pubmed: 32839582
J Biol Chem. 1993 Dec 15;268(35):26033-6
pubmed: 8253711
Methods Cell Biol. 2018;143:171-185
pubmed: 29310777
J Biol Chem. 2021 Jan-Jun;296:100591
pubmed: 33775698
J Biol Chem. 2000 Feb 25;275(8):6030-7
pubmed: 10681598
Kidney Int. 1982 Apr;21(4):642-52
pubmed: 7047864
J Biol Chem. 2019 May 17;294(20):7968-7981
pubmed: 30923125
J Cell Biol. 2016 May 23;213(4):479-94
pubmed: 27216258
Science. 1990 Jun 8;248(4960):1224-7
pubmed: 2349482
J Biol Chem. 2008 Dec 12;283(50):35070-7
pubmed: 18930919
J Liq Chromatogr Relat Technol. 2012 Nov;35(20):2923-2950
pubmed: 23378719
N Engl J Med. 2010 Jul 22;363(4):343-54
pubmed: 20660402
Methods Cell Biol. 2018;143:1-39
pubmed: 29310772
J Biol Chem. 2021 Jan-Jun;296:100590
pubmed: 33774048
J Biol Chem. 1987 Jun 5;262(16):7874-7
pubmed: 2438283
Biophys J. 2010 Jun 16;98(12):3004-14
pubmed: 20550913
J Biol Chem. 1990 Apr 5;265(10):5466-9
pubmed: 2318822
Am J Hum Genet. 1990 Jun;46(6):1024-33
pubmed: 2339699
Eur J Biochem. 1981 Nov;120(2):203-11
pubmed: 6274634
Science. 2009 Sep 4;325(5945):1230-4
pubmed: 19729652
J Cell Biol. 1987 Dec;105(6 Pt 1):2559-68
pubmed: 3693393
J Biol Chem. 2005 Jul 22;280(29):27147-54
pubmed: 15917228
J Biol Chem. 1985 Jul 15;260(14):8564-70
pubmed: 2409091

Auteurs

Vadim Pedchenko (V)

Department of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Center for Matrix Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Sergei P Boudko (SP)

Department of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Center for Matrix Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Department of Biochemistry, Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, USA.

Mary Barber (M)

Aspirnaut, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Tatiana Mikhailova (T)

Aspirnaut, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Juan Saus (J)

Department de Bioquímica y Biología Molecular at Facultad de Medicina y Odontología, University de València, Valencia, Spain.

Jean-Christophe Harmange (JC)

Goldfinch Bio, Cambridge, Massachusetts, USA.

Billy G Hudson (BG)

Department of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Center for Matrix Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Department of Biochemistry, Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, USA; Aspirnaut, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, USA; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee, USA; Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee, USA. Electronic address: billy.hudson@vumc.org.

Articles similaires

T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis

Prevalence and implications of fragile X premutation screening in Thailand.

Areerat Hnoonual, Sunita Kaewfai, Chanin Limwongse et al.
1.00
Humans Fragile X Mental Retardation Protein Thailand Male Female
Humans Receptors, Antigen, T-Cell Proto-Oncogene Proteins p21(ras) Pancreatic Neoplasms T-Lymphocytes

Classifications MeSH